Universidad Nacional de Colombia-ko ikertzaileekin lankidetzan egindako argitalpenak (19)

2024

  1. In-vitro antibiofilm activity of polycaprolactone- poly (lactic-co-glycolic acid) nanofibers loaded amphotericin B, antimicrobial peptide LfcinB (21–25)Pal and zinc oxide for local treatment of periodontitis associated with obstructive sleep apnea

    Journal of Drug Delivery Science and Technology, Vol. 94

2023

  1. Combining the Peptide RWQWRWQWR and an Ethanolic Extract of Bidens pilosa Enhances the Activity against Sensitive and Resistant Candida albicans and C. auris Strains

    Journal of Fungi, Vol. 9, Núm. 8

  2. Evaluating the In Vitro Activity and Safety of Modified LfcinB Peptides as Potential Colon Anticancer Agents: Cell Line Studies and Insect-Based Toxicity Assessments

    ACS Omega, Vol. 8, Núm. 41, pp. 37948-37957

  3. Peptide-Resorcinarene Conjugates Obtained via Click Chemistry: Synthesis and Antimicrobial Activity

    Antibiotics, Vol. 12, Núm. 4

  4. Proteomics and Genetic Approaches Elucidate the Circulation of Low Variability Staphylococcus aureus Strains on Colombian Dairy Farms

    Microbial Ecology, Vol. 86, Núm. 4, pp. 2320-2329

2022

  1. Changes in Length and Positive Charge of Palindromic Sequence RWQWRWQWR Enhance Cytotoxic Activity against Breast Cancer Cell Lines

    ACS Omega

  2. Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II: Antifungal Activity against Reference Strains and Clinical Isolates of Candida spp.

    Antibiotics, Vol. 11, Núm. 11

  3. In Vitro Antifungal Activity of Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II against Cryptococcus neoformans var. grubii

    Antibiotics, Vol. 11, Núm. 12

2021

  1. Designing Chimeric Peptides: A Powerful Tool for Enhancing Antibacterial Activity

    Chemistry and Biodiversity, Vol. 18, Núm. 2

  2. Effects of Substituting Arginine by Lysine in Bovine Lactoferricin Derived Peptides: Pursuing Production Lower Costs, Lower Hemolysis, and Sustained Antimicrobial Activity

    International Journal of Peptide Research and Therapeutics, Vol. 27, Núm. 3, pp. 1751-1762

  3. Phospholipid-conjugated peg-b-pcl copolymers as precursors of micellar vehicles for amphotericin b

    Polymers, Vol. 13, Núm. 11

2020

  1. Development of amphotericin b micellar formulations based on copolymers of poly(Ethylene glycol) and poly(ε-caprolactone) conjugated with retinol

    Pharmaceutics, Vol. 12, Núm. 3

  2. Palindromic Peptide LfcinB (21-25)Pal Exhibited Antifungal Activity against Multidrug-Resistant Candida

    ChemistrySelect, Vol. 5, Núm. 24, pp. 7236-7242

  3. Selective cytotoxic effect against the MDA-MB-468 breast cancer cell line of the antibacterial palindromic peptide derived from bovine lactoferricin

    RSC Advances, Vol. 10, Núm. 30, pp. 17593-17601

2019

  1. Colombian consensus on the diagnosis, treatment, and prevention of Candida spp. disease in children and adults

    Infectio, Vol. 23, Núm. 3, pp. 271-304

  2. Enhancing the performance of PEG-b-PCL copolymers as precursors of micellar vehicles for amphotericin B through its conjugation with cholesterol

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 572, pp. 79-87

2017

  1. Invasive infections with multidrug-resistant yeast Candida auris, Colombia

    Emerging Infectious Diseases

2015

  1. Design of Micelle Nanocontainers Based on PDMAEMA-b-PCL-b-PDMAEMA Triblock Copolymers for the Encapsulation of Amphotericin B

    AAPS PharmSciTech, Vol. 16, Núm. 5, pp. 1069-1078

2008

  1. Presencia de Aspergillus spp. en áreas de riesgo en pacientes trasplantados en un hospital universitario

    Revista Iberoamericana de Micologia, Vol. 25, Núm. 4, pp. 232-236